Indeed, expansion of the QA-repeat of TCERG1/CA150 can lead to an earlier onset of HD (60), presumably by placing a burden around the cellular proteostasis system (10)

Indeed, expansion of the QA-repeat of TCERG1/CA150 can lead to an earlier onset of HD (60), presumably by placing a burden around the cellular proteostasis system (10). directing them into nontoxic aggregates. Keywords:protein aggregation, protein misfolding, neurodegeneration, prion, polyglutamine proteins == Abstract == Growth of a poly-glutamine (polyQ) repeat in a group of functionally unrelated proteins is the cause of several inherited neurodegenerative disorders, including Huntingtons disease. The polyQ length-dependent aggregation and toxicity of these disease proteins can be reproduced inSaccharomyces cerevisiae. This system allowed us to screen for genes that when overexpressed reduce the harmful effects of an N-terminal fragment of mutant huntingtin with 103 Q. Surprisingly, among the recognized suppressors were three proteins with Q-rich, prion-like domains (PrDs): glycine threonine serine repeat protein (Gts1p), nuclear polyadenylated RNA-binding protein 3, and minichromosome maintenance protein 1. Overexpression of Etamicastat the PrD of Gts1p, made up of an imperfect 28 residue glutamine-alanine repeat, was sufficient for suppression of toxicity. Association with this discontinuous polyQ domain name did not prevent 103Q aggregation, but altered the physical properties of the aggregates, most likely early in the assembly pathway, as reflected in their increased SDS solubility. Molecular simulations suggested that Gts1p arrests the aggregation of Etamicastat polyQ molecules at the level of nonfibrillar species, acting as a cap that destabilizes intermediates on path to form large fibrils. Quantitative proteomic analysis of polyQ interactors showed that expression of Gts1p reduced the conversation between polyQ and other prion-like proteins, and enhanced the association of molecular chaperones with the aggregates. These findings demonstrate that short, Q-rich peptides are Etamicastat able to shield the interactive surfaces of harmful forms of polyQ proteins and direct them into nontoxic aggregates. Expansion of a poly-glutamine (polyQ) repeat in normally unrelated proteins is the cause of several inherited neurological disorders, including Huntingtons disease (HD), spinobulbar muscular atrophy, dentatorubral-pallidoluysian atrophy, and spinocerebellar ataxias 1, 2, 3, 6, 7, and 17 (1). In all these cases, increasing the length of the polyQ repeat over a critical threshold (above 37 Q in HD) (2) results in disease manifestation, with the length of the repeat correlating inversely with age of disease onset (3). According to the gain-of-toxic function theory, the polyQ expansions increase aggregation propensity and confer to the disease proteins the ability to populate one or more harmful conformations, most likely including numerous oligomeric and higher-order aggregate says. These aggregate species vary greatly in quantity of monomeric models, detergent solubility, binding of dyes, and identity and mobility of interacting proteins (46). A prominent hypothesis suggests that the pathologic protein aggregates expose novel, highly interactive surfaces that mediate aberrant interactions with other proteins, resulting in their functional impairment and sequestration (79). Moreover, the aggregation process is thought to interfere with general protein quality control pathways, including protein folding and the clearance of misfolded proteins (1013). The yeastS. cerevisiaehas been used extensively as a model to explore the basic mechanisms of toxicity mediated by polyQ expansions. The polyQ length dependence of aggregation has been reproduced in yeast upon expression of N-terminal fragments of huntingtin made up of the polyQ stretch (N-Htt) (14,15). Interestingly, toxicity, as measured by growth impairment, was found to depend critically around the properties of the sequences flanking the polyQ region (16). Like mammalian prions, yeast prions are able to cause detectable Etamicastat phenotypes without transmitting any genetic material (17), and bothN-Htt aggregation and toxicity were shown Etamicastat to require the [RNQ+] prion (18,19). Although there are numerous proteins in the yeast proteome that contain Q-rich regions (20), there is no Htt homolog in yeast. Therefore, any harmful effects observed in this model system onN-Htt expression can be attributed to a gain-of-toxic function. Although polyQ aggregation is usually strongly associated with cell toxicity, the exact nature and the conformational properties of the harmful polyQ species remain elusive. To gain insight into the basic mechanisms of polyQ toxicity, we performed an unbiased yeast genetic screen for suppressors of the growth defect caused by the expression of polyQ expandedN-Htt. We recognized CCNH six genes that reproducibly restored cell growth when overexpressed. Surprisingly, these suppressors include.